Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 52 clinical trials
Efficacy and Safety of Bevacizumab in the Neodjuvant Treatment of Inflammatory Breast Cancer

Multi-center, non randomised, open label, non controlled pilot study. Evaluating the treatment of bevacizumab in association with pre-operative chemotherapy, followed by surgery, adjuvant chemotherapy and radiotherapy in Patients with inflammatory breast cancer.

ejection fraction
metastasis
trastuzumab
neutrophil count
cyclophosphamide
  • 13 views
  • 07 Nov, 2020
  • 1 location
Camrelizumab Combined With AVD in the First-line Treatment for Patients With Advanced Classical Hodgkin's Lymphoma

This is a prospective phase II clinical trial to observe the efficacy and safety of Camrelizumab combined with AVD in the first-line treatment for patients with advanced classical Hodgkin's lymphoma.

vincristine
dacarbazine
lymphoma
camrelizumab
epirubicin
  • 0 views
  • 27 Jan, 2021
  • 1 location
Xeloda Plus Paclitaxel in Gastric Cancer With Liver Metastasis

To investigate the efficacy of capecitabine combined with paclitaxel as neoadjuvant chemotherapy for gastric cancer with liver metastasis only

cancer chemotherapy
carcinoma
metastasis
capecitabine
xeloda
  • 16 views
  • 08 Nov, 2020
  • 1 location
Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Epirubicin in the Neoadjuvant Therapy for Breast Cancer

-paclitaxel plus carboplatin versus nab-paclitaxel plus epirubicin, in order to provide support for rational clinical application. The total number of patients to be included in this study is 520

triple negative breast cancer
measurable disease
breast cancer
adjuvant therapy
progesterone
  • 0 views
  • 23 Jan, 2021
  • 1 location
TA(E)C-GP Versus A(E)C-T for the High Risk TNBC Patients and Validation of the mRNA-lncRNA Signature

The purpose of this study is to compare the efficacy and safety between docetaxel combined with doxorubicin (epirubicin) and cyclophosphamide followed by gemcitabine combined with cisplatin and

carcinoma
doxorubicin
carcinoma in situ
triple negative breast cancer
cancer
  • 2 views
  • 24 Jan, 2021
  • 1 location
Adjuvant Treatment of EC Followed by Taxane +/- Carboplatin in Triple-Negative Breast Cancer

To compare disease-free survival (DFS) rate of adjuvant chemotherapy epirubicin-cyclophosphamide followed by weekly paclitaxel or docetaxel (EC-T), or weekly paclitaxel or docetaxel-carboplatin

carcinoma
adjuvant chemotherapy
taxane
triple negative breast cancer
immunostimulant
  • 90 views
  • 24 Jan, 2021
  • 27 locations
Study Comparing EC-T Verses PCb in the Adjuvant Chemotherapy of Non-triple Negative Breast Cancer

This study is a randomized, single center, phase III clinical trial comparing the efficacy and safety of four cycles of epirubicin combined with cyclophosphamide followed by four cycles of

epidermal growth factor receptor
adjuvant chemotherapy
pertuzumab
triple negative breast cancer
immunostimulant
  • 2 views
  • 23 Jan, 2021
  • 1 location
Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo

doxorubicin and cyclophosphamide (AC) or epirubicin and cyclophosphamide (EC). Usually, after neoadjuvant therapy and surgery for triple negative breast cancer, no additional treatment is given unless the

core needle biopsy
atezolizumab
programmed cell death 1 ligand 1
platelet count
cyclophosphamide
  • 1000 views
  • 27 Jan, 2021
  • 205 locations
Adjuvant Palbociclib in Elderly Patients With Breast Cancer

Phase II study to assess the efficacy of the combination of at least 5 year endocrine therapy and 2 year-palbociclib as adjuvant systemic treatment instead of adjuvant chemotherapy followed by endocrine therapy in older patients with stage II-III ER+/HER2- early breast cancer.

anthracyclines
core needle biopsy
adjuvant chemotherapy
taxane
her-2
  • 4 views
  • 28 Jan, 2021
  • 63 locations
Epirubicin Oxaliplatin and Capecitabine or Docetaxel and Oxaliplatin in Treating Patients With Advanced Esophageal Cancer Gastroesophageal Junction Cancer or Stomach Cancer

RATIONALE: Drugs used in chemotherapy, such as epirubicin, oxaliplatin, capecitabine, and docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells

combination chemotherapy
docetaxel
oxaliplatin
capecitabine
tumor cells
  • 134 views
  • 07 Nov, 2020
  • 3 locations